- 2023
-
Press releases - 27.06.2023
Neurodevelopmental Disorders in Children: A New Gene Called Into Question
In the face of childhood neurodevelopmental disorders, how can we get out of the therapeutic “dead end”? The answer could well be found in the genes of the proteasome – an intracellular mechanism that is responsible for removing defective proteins from the cell.
-
Press releases - 22.06.2023
A Surprising Discovery About the Pulse
We are all familiar with taking our pulse to check our heart rate. This signal is due to the propagation of a wave caused by the arteries dilating under the surge of blood from the heart.
-
Press releases - 20.06.2023
How Blood Stem Cells Detect Pathogens and Guide Immune Response
Correct immune system function depends on the continuous supply of white blood cells derived from stem cells that reside in the bone marrow. These are known as blood stem cells or hematopoietic stem cells. Researchers from Inserm, CNRS and Université d’Aix-Marseille at the Center of Immunology Marseille-Luminy have now discovered a new role played by these cells in immune response.
-
Press releases - 08.06.2023
When We Always Benefit From Focusing on Health: Inserm Unveils Its New Advertising Campaign
One year after its large-scale poster campaign in France’s railway stations and Paris subway, Inserm uses its slogan On gagne tous les jours à s’intéresser à la santé [We always benefit from focusing on health] in a 30-second TV commercial broadcast from June 7 to July 30.
-
Press releases - 02.06.2023
Immunotherapy for blood cancer: remote destruction of tumor cells demonstrated
CAR T cell therapy is an immunotherapy that is effective in treating blood cancer. By closely investigating some of the immune cells generated during this therapy, known as CD4 T cells, scientists from the Institut Pasteur and Inserm, in collaboration with clinicians from the Paris Public Hospital Network (AP-HP), discovered that these cells are capable of remotely neutralizing tumor cells by producing interferon gamma (IFN-γ).
-
Press releases - 31.05.2023
A Major Advance in the Genetics and Risk Factors of a Form of Infarction That Mainly Affects Women
In order to understand its genetic causes and biological mechanisms, a new international study led by Inserm Research Director Nabila Bouatia-Naji at the Paris-Cardiovascular Research Center – PARCC (Inserm/Université Paris Cité) was set up. Its findings show the genetic causes that define the risk of SCAD to be very numerous and distributed across the entire patient genome.
-
Press releases - 25.05.2023
InScience 2023: The Festival That Does Your Health Good
June 1 to 15, 2023 will mark the third edition of InScience – a festival held by Inserm for visitors to discover and discuss questions of health and medical research.
-
Press releases - 17.05.2023
Women and Parkinson’s Disease: Physical Activity Found to Be Beneficial More Than Twenty Years Before Diagnosis
Researchers from Inserm, Université Paris-Saclay and Université de Versailles Saint-Quentin-en-Yvelines (UVSQ) with the Gustave Roussy Institute studied the impact of physical activity on the development of PD in nearly 100,000 women from the French cohort E3N followed up over 29 years.
-
Press releases - 16.05.2023
Eating Broccoli to Limit Skin Allergies
The severity of skin allergies can vary depending on many environmental factors, including diet.
-
Press releases - 15.05.2023
Health Outcomes of the Nuclear Tests in French Polynesia
The health outcomes of the nuclear tests performed in French Polynesia in the 1970s have been the subject of epidemiological studies at Inserm for several years. In a new publication, the scientists confirm these findings and conduct a risk prediction analysis showing that these nuclear tests could be responsible for 2.3% of the thyroid cancer cases.